Clinical Trials Directory

Trials / Completed

CompletedNCT01618058

Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials

A Long-Term Observational Cohort Study of HIV Infection in Participants Who Seroconvert After Enrolment in Dapivirine Vaginal Ring Trials

Status
Completed
Phase
Study type
Observational
Enrollment
151 (actual)
Sponsor
International Partnership for Microbicides, Inc. · Industry
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this trial is to determine if exposure to ARV-containing investigational products in IPM clinical trials will impact the natural history of HIV infection as measured by the virologic, immunologic and clinical outcomes of participants who become HIV-positive during the IPM 027 trial.

Conditions

Interventions

TypeNameDescription
DRUGNo Investigational ProductThis study is observational in nature and no investigational product will be used. Groups: ARV-Treated Participants, ARV-Naive Participants

Timeline

Start date
2012-10-04
Primary completion
2019-08-06
Completion
2019-08-06
First posted
2012-06-13
Last updated
2019-09-06

Locations

5 sites across 2 countries: Rwanda, South Africa

Source: ClinicalTrials.gov record NCT01618058. Inclusion in this directory is not an endorsement.

Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials (NCT01618058) · Clinical Trials Directory